|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During Thermo Fisher's investor day yesterday, CEO Marc Casper doubled down on the mass onshoring to the US as a "once in a lifetime" opportunity for its business. Tool and equipment suppliers like Thermo have already touted they stand to profit as more drugmakers move to the US. |
|
|
|
Anna Brown |
Biopharma Breaking News Reporter, Endpoints News
|
|
|
|
|
|
|
by Reynald Castaneda, Anna Brown
|
European healthcare investor GHO Capital and asset management firm CBC Group are set to join forces, with the new entity to manage over $21 billion... | |
|
|
|
 |
|
President Donald Trump with Mark Cuban and CMS Administrator Mehmet Oz on May 18, 2026 (Julia Demaree Nikhinson/AP Images) |
|
|
|
by Max Bayer
|
The Trump administration is significantly building the portfolio of drugs available through its direct-to-consumer platform TrumpRx, adding more than 600 generic medicines. President Donald Trump... | |
|
|
|
|
|
|
by Elizabeth Cairns
|
One of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been approved by the FDA, the drugmaker said... | |
|
|
|
|
|
|
by Anna Brown
|
Plus, news about Gilead and West Pharma: 🏭Bristol Myers Squibb looks to Texas: The drugmaker is considering buildinga new pharma campus in
Generation Park... | |
|
|
|
|
|
|
|
Worldwide made. Thanks for reading.
|
|
|
|
|
|
|
|
